» Articles » PMID: 27839944

Authors' Reply

Overview
Authors
Affiliations
Soon will be listed here.
References
1.
Straburzynska-Lupa A, Nowak A, Romanowski W, Korman P, Pilaczynska-Szczesniak L . A study of the link between bone turnover markers and bone mineral density with inflammation and body mass in postmenopausal women with active rheumatoid arthritis. J Bone Miner Metab. 2012; 31(2):169-76. DOI: 10.1007/s00774-012-0400-2. View

2.
Khosla S . Minireview: the OPG/RANKL/RANK system. Endocrinology. 2001; 142(12):5050-5. DOI: 10.1210/endo.142.12.8536. View

3.
Lekkerkerker F, Kanis J, Alsayed N, Bouvenot G, Burlet N, Cahall D . Adherence to treatment of osteoporosis: a need for study. Osteoporos Int. 2007; 18(10):1311-7. DOI: 10.1007/s00198-007-0410-4. View

4.
Atbinici H, Sipahioglu S, Aksoy N, Baykara I, Isikan U . Effects of salmon calcitonin treatment on serum and synovial fluid bone formation and resorption markers in osteoporosis patients. Acta Orthop Traumatol Turc. 2015; 49(2):160-5. DOI: 10.3944/AOTT.2015.3035. View

5.
Crotti T, Smith M, Findlay D, Zreiqat H, Ahern M, Weedon H . Factors regulating osteoclast formation in human tissues adjacent to peri-implant bone loss: expression of receptor activator NFkappaB, RANK ligand and osteoprotegerin. Biomaterials. 2003; 25(4):565-73. DOI: 10.1016/s0142-9612(03)00556-8. View